Nature of the Event
This is a regulatory disclosure regarding the allotment of equity shares to employees pursuant to the exercise of stock options under the company's ESOP plan. The disclosure is made under Regulation 30 of the SEBI (LODR) Regulations, 2015.
Key Quantitative Figures
- Number of shares allotted: 2,047 equity shares
- Face value per share: ₹2
- Exercise prices per share: ₹1,040, ₹1,620, and ₹2,000
- Premium per share: ₹1,038, ₹1,618, and ₹1,998 (corresponding to the exercise prices)
- Pre-allotment paid-up capital: ₹10,22,92,354, comprising 5,11,46,177 equity shares
- Post-allotment paid-up capital: ₹10,22,96,448, comprising 5,11,48,224 equity shares
- Distinctive numbers of allotted shares: 5,11,46,178 to 5,11,48,224
Dates of Action
- Date of circular resolution: September 17, 2026
- Date of share issue: September 17, 2026
Parties Involved
- Approving body: Nomination and Remuneration Committee of the Board of Directors
- Recipients: Eligible employees of the company
- Regulatory references: SEBI (LODR) Regulations, 2015 (Reg. 30); SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (Reg. 10(c))
Purpose or Rationale
The allotment was made pursuant to the exercise of stock options granted under the 'ALKYL AMINES CHEMICALS LIMITED (AACL) - EMPLOYEES STOCK OPTION PLAN 2018 (ESOP-2018)'.
Capital Structure Impact
The allotment has resulted in a minor increase in the company's paid-up share capital. The number of equity shares increased from 5,11,46,177 to 5,11,48,224.
Additional Details
- The shares were issued in dematerialized form.
- No lock-in period is applicable to the allotted shares.
- The newly issued shares are identical in all respects and will rank pari passu with the existing equity shares of the company.
- No additional listing fees are payable for these shares as the company's paid-up capital remains within the ₹100 crore slab for which fees have already been paid.